Clinical Trial Update: Treatment for Completers of the Study B7A-MC-MBCM [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating treatment for completers of study B7A-MC-MBCM in diabetic retinopathy has completed, with results posted in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: Chromaderm, Inc. | Conditions: Diabetic Retinopathy | Phase 3 | Status: COMPLETED | Results posted: 2016-01-28